Beta Blockers May Cause Sleep Problems, But Not Depression: Study

The side effects of beta blockers may increase the likelihood of experiencing sleep problems or having unusual dreams, according to the findings of a new study. However, the drugs do not appear to increase the risk of depression, which has been a concern highlighted in earlier research.

In a report published this week in the medical journal Hypertension, German researchers evaluated the psychiatric impact of beta blockers, which includes brand name medications like Lopressor, Normodyne, Tenormin, and InnoPran XL.

The drugs are commonly used to treat cardiovascular diseases, including heart failure, chest pain, high blood pressure and abnormal heart rhythm. Prior studies have suggested the medications may cause a number of side effects, including depression, anxiety, drowsiness, insomnia, hallucinations and nightmares. However, while the new findings do indicate the medications cause sleep disturbances, depression did not occur more commonly when compared to use of a placebo.

Do You Know About...

Childhood Diabetes Lawsuits Against Junk Food Industry

Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods.

Learn More

Researchers used data from 285 eligible studies, including more than 53,000 patients. Most of the studies used were double-blind, randomized controlled trails, primarily focusing on high blood pressure treatment. Of those, 31 studies assessed depression in placebo-controlled trials.

The new findings appear to contradict prior research that has suggested a link between depression and beta blockers.

Researchers indicate drugs like Lopessor and Normodyne do not increase the risk of depression or withdrawal for depression. However, the new study did find a link between taking beta blockers and patients having unusual dreams, insomnia, and sleep disturbances.

This is an analysis of large scale data from double blind randomized controlled trials. Researchers said the findings are compelling because double-blind randomized controlled trials are used to prove cause-and-effect, compared to large retrospective studies which only indicate an association.

“(N)o effect for beta blockers was found for other psychiatric adverse events, with the possible exceptions of sleep-related disorders,” the researchers concluded. “Consequently, concerns about beta blockers’ impact on psychological health should not affect their use in clinical practice.”

0 Comments

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court
Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (Posted yesterday)

A federal judge has issued pretrial schedules for the first two BioZorb lawsuits to go before juries starting in September, calling for the parties to outline all the issues of contention, witnesses and facts to be presented during the bellwether early test cases.

Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week
Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (Posted 3 days ago)

A federal magistrate judge has accepted new deadlines for expert discovery in Covidien hernia mesh lawsuits, which will also result in the selection of a mediator by February 24, to shepherd the parties through settlement negotiations.